Supplements

Arterosil HP

Overview

Effectiveness rated 45 due to promising but weak evidence: one n=6 case series (conflict of interest, not RCT) showing plaque regression via glycocalyx support, plus small open-label trials on rhamnan sulfate for NO/lipids/BP, and moderate/strong data on secondary polyphenols (e.g., green tea catechins reduce LDL per meta-analyses; grape seed lowers BP). Lacks large RCTs/meta-analyses for arterial plaque reduction. Safety high (95) as no side effects in studies/FDA reports. Quality moderate (55)

Key strengths

Our analysis

Average (59/100) - Effectiveness rated 45 due to promising but weak evidence: one n=6 case series (conflict of interest, not RCT) showing plaque regression via glycocalyx support, plus small open-label trials on rhamnan sulfate for NO/lipids/BP, and moderate/strong data on secondary polyphenols (e.g., green tea catechins reduce LDL per meta-analyses; grape seed lowers BP). Lacks large RCTs/meta-analyses for arterial plaque reduction. Safety high (95) as no side effects in studies/FDA reports. Quality moderate (55) for cGMP/purity claims but penalized for opaque proprietary 900mg blend (unknown rhamnan sulfate dose vs. study blend), absence of third-party certifications, and high cost vs. cheaper polyphenol alternatives like standalone grape seed (150mg ~$10/mo) or green tea extract.

Frequently asked questions

Is Arterosil HP worth buying?
Arterosil HP has a Verify Influencers trust score of 59/100 based on ingredient quality, clinical evidence, and third-party testing.
What is the trust score for Arterosil HP?
Arterosil HP scored 59 out of 100 in our science-backed analysis, which evaluates ingredient dosages against clinical literature and manufacturing transparency.

Browse all scored products · How products are scored